LAS VEGAS—Not all hazardous drugs need to be handled according to the full gamut of measures specified in USP General Chapter <800>, an expert reminded attendees of the 2019 MHA Business Summit.
“A lot of people think they need to treat everything using all the strict requirements of USP <800>, but this can be really burdensome if all these measures are not necessary, based on the risk,” said Joseph Coyne, RPh, the director of field operations at Clinical IQ LLC, a